Model based process design for bioprocess optimisation: case studies on precipitation with its applications in antibody purification.
Doctoral thesis, UCL (University College London).
Developing a bioprocess model can not only reduce cost and time in process development, but now also assist the routine manufacturing and guarantee the quality of the final products through Quality by Design (QbD) and Process Analytical Technology (PAT). However, these activities require a model based process design to efficiently direct, identify and execute optimal experiments for the best bioprocess understanding and optimisation. Thus an integrated model based process design methodology is desirable to significantly accelerate bioprocess development. This will help meet current urgent clinical demands and also lower the cost and time required. This thesis examines the feasibility of a model based process design for bioprocess optimisation. A new process design approach has been proposed to achieve such optimal design solutions quickly, and provide an accurate process model to speed up process understanding. The model based process design approach includes bioprocess modelling, model based experimental design and high throughput microwell experimentation. The bioprocess design is based on experimental data and a computational framework with optimisation algorithm. Innovative model based experimental design is a core part in this approach. Directed by the design objectives, the method uses D-optimal design to identify the most information rich experiments. It also employs Random design and Simplex to identify extra experiments to increase the accuracy, and will iteratively improve the process design solutions. The modelling and implementation method by high throughput experimentation was first achieved and applied to an antibody fragment (Fab’) precipitation case study. A new precipitation model based on phase equilibrium has been developed using the data from microwell experimentation, which was further validated by statistical tests to provide high confidence. The precipitation model based on good data accurately describes not only the Fab' solubility but also the solubility of impurities treated as a pseudo-single protein, whilst changing two critical process conditions: salt concentration and pH. The comparison study has shown the model was superior to other published models. The new precipitation model and the Fab' microwell data provided the basis to test the efficiency and robustness of the algorithms in model based process design approach. The optimal design solution with the maximum objective value was found by only 5 iterations (24 designed experimental points). Two parameterised models were obtained in the end of the optimisation, which gave a quantitative understanding of the processes involved. The benefit of this approach was well demonstrated by comparing it with the traditional design of experiments (DoE). The whole model based process design methodology was then applied to the second case study: a monoclonal antibody (mAb) precipitation process. The precipitation model was modified according to experimental results following modelling procedures. The optimal precipitation conditions were successfully found through only 4 iterations, which led to an alternative process design to protein A chromatography in the general mAb purification platform. The optimal precipitation conditions were then investigated at lab scale by incorporating a depth filtration process. The final precipitation based separation process achieved 93.6% (w/w) mAb yield and 98.2 % (w/w) purity, which was comparable to protein A chromatography. Polishing steps after precipitation were investigated in microwell chromatographic experimentation to rapidly select the following chromatography steps and facilitate the whole mAb purification process design. The data generated were also used to evaluate the process cost through process simulations. Both precipitation based and protein A chromatography based processes were analysed by the process model in the commercial software BioSolve under several relevant titre and scale assumptions. The results showed the designed precipitation based processes was superior in terms of process time and cost when facing future process challenges.
|Title:||Model based process design for bioprocess optimisation: case studies on precipitation with its applications in antibody purification|
|Open access status:||An open access version is available from UCL Discovery|
|UCL classification:||UCL > School of BEAMS > Faculty of Engineering Science > Biochemical Engineering|
Archive Staff Only